Clinical Trials Browser

Enrolling by invitation × Chemoradiotherapy × 90 days × Clear all

NCT07386704 2026-02-04

Nimotuzumab Combined With Chemoradiotherapy in the Treatment of Unresectable Locally Advanced or Oligometastatic Pancreatic Cancer

Phase 2 Enrolling by invitation

Gastrointestinal

Pancreatic Cancer Non-resectable

NCT07346248 2026-01-16

POCAT

Enrolling by invitation

Gastrointestinal

Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery